MAPT and Cognitive impairment: The disappointing clinical outcomes of various anti‐Aβ therapeutics have shifted researchers’ interests toward tau‐based therapy for treating cognitive deficits.[215] Tau protein plays a pivotal role in maintaining microtubule stabilization during neuronal transport.